BioSpace News Archive

BioKansas, a non-profit organization supporting the bioscience industry has extended their partnership with the Biotechnology Innovation Organization for a second year.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, announced that senior management will participate in fireside chats at two upcoming virtual investor conferences

Medifast, Inc., the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced that its Board of Directors has declared a $1.42 quarterly cash dividend to its stockholders.

New Coverage Further Validates Laparoscopic Radiofrequency Ablation (Lap-RFA) as a Standard of Care for Uterine Fibroids

CooperCompanies announced financial results for its fiscal second quarter ended April 30, 2021.

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced positive results from the pivotal study “JUPITER-02”, a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab plus chemotherapy

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced first-time results from the pivotal Phase 3 KEYNOTE-564 trial evaluating KEYTRUDA

Kansas Manufacturing Solutions, a trusted advisor to Kansas manufacturers, and BioKansas, a non-profit organization dedicated to supporting and growing Kansas’ bioscience ecosystem, are pleased to announce their new partnership to increase the prosperity of Kansas companies engaged in biomanufacturing.

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), announced that the results from the Phase II MARCH trial of selinexor plus low dose dexamethasone.

Foresight Diagnostics announced today that two abstracts that report the clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) and non-small cell lung cancer (NSCLC) were chosen for presentation at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4-8, 2021.